Taste and Smell Disturbance Resulting From Midodrine
Stephanie Horger1, Stacy Kandrac1, Daniel S Longyhore2
1Department of Pharmacy Practice, Wilkes University, Wilkes-Barre, PA, USA.
Midodrine, used for orthostatic hypotension, may cause taste (dysgeusia) and smell (dysosmia) disturbances. These sensory side effects appear to diminish over time with continued medication use.
Area of Science:
- Pharmacology
- Neurology
- Otolaryngology
Background:
- Midodrine is a common treatment for orthostatic hypotension.
- Adverse sensory events like dysgeusia and dysosmia are not widely reported for midodrine.
Observation:
- A 58-year-old male experienced dysgeusia and dysosmia two weeks after initiating midodrine for orthostatic hypotension.
- The patient also noted a reduced appetite, which he initially attributed to his condition rather than the medication.
Findings:
- Dysgeusia and dysosmia are potential, albeit uncommon, adverse effects of midodrine.
- These sensory disturbances may decrease in severity or resolve with ongoing midodrine treatment.
Implications:
- Clinicians should consider midodrine as a potential cause of dysgeusia and dysosmia in patients.
- Further research is needed to understand the dose-dependency and prevalence of these sensory side effects.
More Related Videos
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Cholinergic Antagonists: Pharmacokinetics
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
